Liver Steatosis in Pediatric CD Patients

Recruiting Observational Study
Celiac Disease in Children Non-Alcoholic Fatty Liver Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 14
Sex
Any
Study type
Observational
Participants needed
91 (estimated)
Sponsor
University of Palermo · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Celiac disease (CD) is an autoimmune enteropathy triggered by the intake of gluten, characterized by a genetic predisposition. Although, CD is often associated with malabsorption symptoms, a growing number of affected subjects are overweight or frankly obese. One of the conditions that is most frequently detected in pauci/asymptomatic subjects is an increase in transaminases, which often regresses…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>1 and \<14 years * Celiac Disease diagnosis according European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) criteria Exclusion Criteria: * age \<1 and \>14 years; * self-exclusion of gluten/wheat from the diet and refusal to reintroduce it…
Contacts

Aurelio Seidita, MD

00390916802764

aurelio.seidita@unipa.it

CONTACT

Antonio Carroccio, MD

00390916802764

antonio.carroccio@unipa.it

CONTACT